The prevalence and genotype of human papillomavirus on cervical samples from an Irish female population with external genital warts.

Hdl Handle:
http://hdl.handle.net/10147/275812
Title:
The prevalence and genotype of human papillomavirus on cervical samples from an Irish female population with external genital warts.
Authors:
Cremin, Suzanne M; Menton, John F; Canier, Lydie; Horgan, Mary; Fanning, Liam J
Affiliation:
STI Clinic, Infirmary, South Victoria University Hospital, Cork, Ireland. suzannem.cremin@hse.ie
Citation:
The prevalence and genotype of human papillomavirus on cervical samples from an Irish female population with external genital warts. 2012, 8 (7):916-20 Hum Vaccin Immunother
Journal:
Human vaccines & immunotherapeutics
Issue Date:
Jul-2012
URI:
http://hdl.handle.net/10147/275812
DOI:
10.4161/hv.20122
PubMed ID:
22777095
Abstract:
The aim of this study was to determine the cervical genotype profile of females who presented to an STI Clinic with external genital warts (EGW); and to determine the potential vaccine coverage prior to the uptake of the HPV vaccines. Sixty-one cervical scrapings were taken from females aged 18-35 y who had external genital warts or a history of external genital warts. The resulting 50 samples that were positive for HPV-DNA were subjected to genotype identification. Forty-six of these samples had detectable genotypes by LIPA analysis and most (78%, 36/46) had multiple low risk (LR) and high risk (HR) genotypes on the cervix. Twenty-five of these samples (54%) had more than 1 HR genotype. Of the 36 patients who had any HR genotypes, 18 (50%) were identified to have the most oncogenic HPV genotypes, namely 16 and 18. Three of these samples had both 16 and 18 on the cervix. The presence of multiple HR genotypes on the majority of cervical samples from a self-referred population of females with EGW is presented. This study is of importance since persistent HR-HPV is the necessary risk factor in the development of precancerous and cancerous lesions of the cervix. Gardisil, the quadrivalent HPV vaccine would have been useful in the prevention of 28% (13/46) of these infections.
Item Type:
Article
Language:
en
MeSH:
Adolescent; Adult; Cervix Uteri; Condylomata Acuminata; Female; Genotype; Humans; Ireland; Papillomaviridae; Papillomavirus Infections; Prevalence; Young Adult
ISSN:
2164-554X

Full metadata record

DC FieldValue Language
dc.contributor.authorCremin, Suzanne Men_GB
dc.contributor.authorMenton, John Fen_GB
dc.contributor.authorCanier, Lydieen_GB
dc.contributor.authorHorgan, Maryen_GB
dc.contributor.authorFanning, Liam Jen_GB
dc.date.accessioned2013-03-25T10:08:45Z-
dc.date.available2013-03-25T10:08:45Z-
dc.date.issued2012-07-
dc.identifier.citationThe prevalence and genotype of human papillomavirus on cervical samples from an Irish female population with external genital warts. 2012, 8 (7):916-20 Hum Vaccin Immunotheren_GB
dc.identifier.issn2164-554X-
dc.identifier.pmid22777095-
dc.identifier.doi10.4161/hv.20122-
dc.identifier.urihttp://hdl.handle.net/10147/275812-
dc.description.abstractThe aim of this study was to determine the cervical genotype profile of females who presented to an STI Clinic with external genital warts (EGW); and to determine the potential vaccine coverage prior to the uptake of the HPV vaccines. Sixty-one cervical scrapings were taken from females aged 18-35 y who had external genital warts or a history of external genital warts. The resulting 50 samples that were positive for HPV-DNA were subjected to genotype identification. Forty-six of these samples had detectable genotypes by LIPA analysis and most (78%, 36/46) had multiple low risk (LR) and high risk (HR) genotypes on the cervix. Twenty-five of these samples (54%) had more than 1 HR genotype. Of the 36 patients who had any HR genotypes, 18 (50%) were identified to have the most oncogenic HPV genotypes, namely 16 and 18. Three of these samples had both 16 and 18 on the cervix. The presence of multiple HR genotypes on the majority of cervical samples from a self-referred population of females with EGW is presented. This study is of importance since persistent HR-HPV is the necessary risk factor in the development of precancerous and cancerous lesions of the cervix. Gardisil, the quadrivalent HPV vaccine would have been useful in the prevention of 28% (13/46) of these infections.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Human vaccines & immunotherapeuticsen_GB
dc.subject.meshAdolescent-
dc.subject.meshAdult-
dc.subject.meshCervix Uteri-
dc.subject.meshCondylomata Acuminata-
dc.subject.meshFemale-
dc.subject.meshGenotype-
dc.subject.meshHumans-
dc.subject.meshIreland-
dc.subject.meshPapillomaviridae-
dc.subject.meshPapillomavirus Infections-
dc.subject.meshPrevalence-
dc.subject.meshYoung Adult-
dc.titleThe prevalence and genotype of human papillomavirus on cervical samples from an Irish female population with external genital warts.en_GB
dc.typeArticleen
dc.contributor.departmentSTI Clinic, Infirmary, South Victoria University Hospital, Cork, Ireland. suzannem.cremin@hse.ieen_GB
dc.identifier.journalHuman vaccines & immunotherapeuticsen_GB
dc.description.provinceMunsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.